Revolutionary Drug Could Be New Hope For Adrenal Cancer Patients
Monday, September 28, 2009 - 00:21
in Health & Medicine
Medical researchers are starting a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. They hope the new compound, OSI-906, which is administered orally, will stop ACC tumor growth -- perhaps even promote tumor shrinkage -- without the toxic side effects of current chemotherapies. The trial will focus on patients with inoperable tumors who have relapsed or failed to respond to conventional therapies.